{"symbol":"BSX","fiscalQuarter":"Q3-2023","reportDate":"2023-10-26","reportTime":"BMO","status":"reported","company":{"name":"Boston Scientific Corporation","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BSX/earnings/Q3-2023","postBrief":{"headline":"Boston Scientific Beats on EPS, Stock Down 0.42%","keyNumbers":[{"metric":"EPS","actual":"$0.50","expected":"N/A","surprise":"+4.82%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management expressed satisfaction with the EPS performance despite not providing revenue figures.","They highlighted ongoing challenges in the market but remain focused on long-term growth."],"summary":"Overall, management conveyed a sense of cautious optimism regarding the company's performance. They acknowledged market challenges but emphasized their commitment to future growth."},"guidanceChanges":{"summary":"No forward guidance was provided in this earnings report.","changes":[]},"whatItMeans":"Boston Scientific's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the stock reacted negatively, declining by 0.42%, which may suggest investor concerns about the lack of revenue information and overall market conditions. The cautious tone from management may also contribute to the stock's downward movement.","metaDescription":"Boston Scientific (BSX) Q3 2023 earnings: EPS beat expectations. Stock down 0.42%. Full breakdown."}}